⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

ALGN

Align Technology, Inc.

Healthcare · Medical Instruments & Supplies

152.92USD

-0.5700 (-0.37%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$2.79▼$2.9112
Next quarter$3.23▼$3.2939
Current year$11.29▼$11.36310
Next year$12.55▲$12.37114

Recent quarters

Beat in 4 of the last 4

QuarterEstimateActualSurprise
2026-06-30$2.6$2.64+0.04 (+1.7%)
2026-03-31$2.29$2.58+0.29 (+12.8%)
2025-12-31$2.97$3.29+0.32 (+10.8%)
2025-09-30$2.41$2.61+0.20 (+8.4%)

Wall Street coverage

286 ratings from 32 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
UBSMaintainedNeutral$186 $189Jul 23, 2026
BMO CapitalInitiatedOutperform$209Jul 9, 2026
Evercore ISI GroupMaintainedOutperform$200 $220Apr 30, 2026
MizuhoMaintainedOutperform$215 $220Apr 30, 2026
Morgan StanleyMaintainedEqual-Weight$169 $188Apr 24, 2026
Piper SandlerMaintainedOverweight$220 $235Apr 21, 2026
CitigroupInitiatedBuy$240Apr 15, 2026
BarclaysUpgraded from Equal-WeightOverweight$200Mar 17, 2026
BarclaysMaintainedEqual-Weight$170 $200Feb 26, 2026
HSBCUpgraded from HoldBuy$150 $200Feb 9, 2026
StifelMaintainedBuy$200 $210Feb 5, 2026
Piper SandlerMaintainedOverweight$200 $220Feb 5, 2026
UBSMaintainedNeutral$175 $185Feb 5, 2026
Evercore ISI GroupMaintainedOutperform$180 $200Feb 5, 2026
Wells FargoMaintainedOverweight$181 $200Feb 5, 2026
Morgan StanleyMaintainedEqual-Weight$154 $169Feb 5, 2026
MizuhoMaintainedOutperform$170 $200Jan 20, 2026
BarclaysInitiatedEqual-Weight$170Dec 9, 2025
Morgan StanleyMaintainedEqual-Weight$142 $154Oct 30, 2025
Evercore ISI GroupMaintainedOutperform$160 $170Oct 30, 2025
Wells FargoMaintainedOverweight$199 $181Oct 30, 2025
Piper SandlerReiteratedOverweight$190 $200Oct 30, 2025
Morgan StanleyMaintainedEqual-Weight$154 $142Oct 21, 2025
UBSMaintainedNeutral$160 $155Oct 16, 2025
MizuhoMaintainedOutperform$210 $170Oct 13, 2025

Insider transactions

30 filings from 15 insiders · 0 buy / 0 sell over 6m

Officers and directors of ALGN, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
Blackford Quentin S.DirectorGrantRestricted Stock Units1.4k——Aug 27, 2026
SIEGEL SUSAN EDirectorOther1.7k——May 20, 2026
LARKIN CHARLES RAYMOND JRDirectorOther2.3k——May 20, 2026
MORROW GEORGE JDirectorOther1.7k——May 20, 2026
LACOB JOSEPH SDirectorOtherindirect1.7k——May 20, 2026
CONROY KEVIN TDirectorOther1.7k——May 20, 2026
SAIA ANDREA LYNNDirectorOther1.7k——May 20, 2026
MYONG ANNEDirectorOther1.7k——May 20, 2026
VITALONE BRITT JDirectorOther1.4k——May 20, 2026
DALLAS KEVIN J.DirectorOther1.7k——May 20, 2026
POUL MOJDEHDirectorOther1.7k——May 20, 2026
HOGAN JOSEPH MChief Executive OfficerOther40.2k——Feb 20, 2026
COLETTI JULIE ANNOfficerOther5.9k——Feb 20, 2026
HOCKRIDGE STUART AOfficerOther4.3k——Feb 20, 2026
MORICI JOHNChief Financial OfficerOther7.8k——Feb 20, 2026
MORICI JOHNChief Financial OfficerSell8.0k$189.31$1.51MFeb 18, 2026
HOGAN JOSEPH MChief Executive OfficerBuy7.6k$131.49$996kAug 1, 2025
MYONG ANNEDirectorOther1.1k——May 21, 2025
SIEGEL SUSAN EDirectorOther1.1k——May 21, 2025
LARKIN CHARLES RAYMOND JRDirectorExercise1.5k——May 21, 2025

Analyst Notes

Sign in to write

No analyst notes on ALGN yet.

Analyst Ratings

15 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current38501Buy2.29
1 mo ago38501Buy2.29
2 mo ago28501Buy2.38
3 mo ago38401Buy2.25
Price target$208.60$170.00 – $240.00
+36.4% to target